Accession Number: | 0001225208-21-000868 |
Date: | 2020-12-14 |
Issuer: | EDWARDS LIFESCIENCES CORP (EW) |
Original Submission Date: |
MUSSALLEM MICHAEL A
ONE EDWARDS WAY
IRVINE, CA 92614
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-12-14 | G | 30,000 | d | $0.00 | 279,570 | direct | ||
COMMON STOCK | 2021-01-15 | M | 98,550 | a | $13.98 | 309,770 | direct | ||
COMMON STOCK | 2021-01-15 | S | 5,308 | d | $87.93 | 304,462 | direct | ||
COMMON STOCK | 2021-01-15 | G | 30,000 | d | $0.00 | 274,462 | direct | ||
COMMON STOCK | 2021-01-15 | S | 63,242 | d | $87.46 | 211,220 | direct | ||
COMMON STOCK | 2021-01-15 | G | 30,000 | a | $0.00 | 2,913,582 | indirect | ||
COMMON STOCK | 2020-12-14 | 0 | $0.00 | 371,737 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO ACQUIRE) | 13.98 | 2021-01-15 | deemed execution date | M | 98,550 (d) | 2014-06-08 | 2021-05-07 | common stock 98,550 | $13.98 | 361,200 | direct |
ID | footnote |
---|---|
f1 | this transaction was executed pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 3, 2020, but was omitted from the last form 4 filed by the reporting person on december 15, 2020. |
f2 | the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on february 3, 2020. |
f3 | this transaction was executed in multiple trades at prices ranging from $87.8400 to $88.1200. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide, upon request by the sec staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. |
f4 | this transaction was executed in multiple trades at prices ranging from $86.8400 to $87.8350. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide, upon request by the sec staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. |
f5 | reflects shares represented on the most recent statement of the issuer's 401(k) plan administrator. |